Shares of Lincoln Pharmaceuticals was up over 3% on the Bombay Stock Exchange after the company said it has developed a new oral spray for the first time in India.
The R&D department has developed Ondansetron Oral Spray (Domi Up). Domi Up Spray is NDDS (Novel Drug Delivery System) formulation, the company said in a release.
The Ondansetron Oral Spray has been launched in the dosage form of 0.2ml equivalent to 2mg and 0.4 ml equivalent to 4mg, the release added.
Ondansetron Oral Spray is more helpful during travelling motion sickness. Its major use is in Oncology patient, when the chemotherapy drug is given, Ondansetron Spray (Domi Up) is having very good results, the release said.
The stock opened at Rs 238 and touched a high of Rs 246. At 10:45am, over 220,000 shares were traded on both the stock exchanges.